D,L-erythro-PDMP hydrochloride

• CAT Number: I041324
• CAS Number: 80943-40-4
• Molecular Formula: C23H39ClN2O3
• Molecular Weight: 427.02
• Purity: ≥95%
• Synonyms: N-[(1S,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]decanamide;hydrochloride
• InChI: InChI=1S/C23H38N2O3.ClH/c1-2-3-4-5-6-7-11-14-22(26)24-21(19-25-15-17-28-18-16-25)23(27)20-12-9-8-10-13-20;/h8-10,12-13,21,23,27H,2-7,11,14-19H2,1H3,(H,24,26);1H/t21-,23+;/m1./s1
• InChIKey: HVJHJOYQTSEKPK-QRIJJCFISA-N
• SMILES: CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](C2=CC=CC=C2)O.Cl

D,L-erythro-PDMP hydrochloride（Cat No.:I041324）is a synthetic compound that acts as an inhibitor of glucosylceramide synthase, an enzyme involved in the biosynthesis of glycosphingolipids. These lipids are crucial for cellular function and signal transduction. By inhibiting this enzyme, D,L-erythro-PDMP hydrochloride has potential therapeutic applications in the treatment of diseases related to abnormal lipid metabolism, such as Gaucher disease, certain cancers, and neurological disorders. It is studied for its ability to alter cellular lipid composition and impact processes like cell growth, differentiation, and apoptosis, with ongoing research into its safety and efficacy.